REVOLVING CREDIT AMENDMENT AGREEMENTRevolving Credit Amendment Agreement • August 2nd, 2013 • Actavis, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 2nd, 2013 Company Industry JurisdictionThis REVOLVING CREDIT AMENDMENT AGREEMENT, dated as of August 1, 2013 (this “Amendment Agreement”), is entered into by and among Actavis, Inc., a Nevada corporation (f/k/a Watson Pharmaceuticals, Inc., the “Company”), the Lenders under the Existing Revolving Credit Agreement (as defined below) that are party hereto (such Lenders, the “Consenting Lenders”, and together with the other Lenders, if any, under the Existing Revolving Credit Agreement that are not party hereto (such other Lenders that are not party hereto, the “Non-Consenting Lenders”), the “Existing Lenders”), the Eligible Assignees party hereto that are not Existing Lenders (the “New Lenders”), and Bank of America, N.A., as administrative agent (in such capacity, the “Administrative Agent”), L/C Issuer and Swing Line Lender.